Studies on Immunobiological Mechanisms in Atherogenesis
动脉粥样硬化形成的免疫生物学机制研究
基本信息
- 批准号:07457047
- 负责人:
- 金额:$ 4.67万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) To elucidate the role of T cell-macrophage interactions in atherogeness we studied the distribution pattern of T cells and macrophages in T cell-depleted athymic homozygous (rnu/rnu) rats fed a cholesterol-enriched diet. In comparison with run/・・・rats, the lesion development was limited in size. whereas foam cell transformation of intimal macrophages was more prominent in rnu/rnu rats. (2) We found that cells from the family of antigen presenting dendritic cells reside in the intima of large arteries. These vascular dendritic cells (VDC) are common in atherosclerotic lesions, and express CDla and S-100. Present ultrastructural examination disclosed in the cytoplasm of VDC Birbeck granule-like structures that are uniquely present in Langerhans cells. Further studies using Lag antibody. which specifically stains Bioreck granules and Biobeck granule-associated structures in Langerhans cells demonstrated that Lag-positive cells were found in the aortic wall. The findings obtained mayimply that mechanisms of antigen presentaion migh be similar to those involved in atherosclerosis. (3) We demonstrated that ICAM-1 expression is up-regulated in the lesionprone areas of aorta in diet-induced hypercholesterolemic rats. Increased expression of [CAM-1 was associated with enhanced macrophage intimal recruitment. Injection of anti-ICAM-1/LFA-1 mab reduced macrophage adherence and their migration into the intima. These results suggest that the ICAM-1/LFA-1 pathway is involved in macrophage-endothelial cell interactions during the early stage of cholesterol-induced atherogenesis. (4) Using a three dimensional culture model simulating in vivo arterial intima. we provided evidence that nLDLs and oxidized LDLs may act as a potential mediator for the increased release of ET-1 in hyperlipidemia and atherosclerosis.
(1)为了阐明T细胞-巨噬细胞相互作用在动脉粥样硬化形成中的作用,我们研究了T细胞耗竭无胸腺纯合子(rnu/rnu)大鼠中T细胞和巨噬细胞的分布模式,这些大鼠喂食富含胆固醇的饮食。与run/··大鼠相比,病变发展的大小有限。而rnu/rnu大鼠内膜巨噬细胞的泡沫细胞转化更为显著。(2)我们发现,来自抗原呈递树突状细胞家族的细胞存在于大动脉的内膜中。这些血管树突状细胞(VDC)在动脉粥样硬化病变中是常见的,并且表达CDla和S-100。目前的超微结构检查在VDC Birbeck颗粒样结构的细胞质中揭示了这种结构,这种结构独特地存在于朗格汉斯细胞中。使用Lag抗体的进一步研究。其特异性染色朗格汉斯细胞中的Bioreck颗粒和Biobeck颗粒相关结构,证明在主动脉壁中发现了Lag阳性细胞。这些发现可能暗示抗原呈递的机制可能与动脉粥样硬化的机制相似。(3)我们证明,ICAM-1的表达上调,在病变的主动脉在饮食诱导的高胆固醇血症大鼠的地区。CAM-1表达的增加与巨噬细胞内膜募集的增强有关。注射抗ICAM-1/LFA-1单抗可减少巨噬细胞粘附及其向内膜的迁移。这些结果表明,ICAM-1/LFA-1途径参与巨噬细胞-内皮细胞相互作用的早期阶段,胆固醇诱导的动脉粥样硬化。(4)采用模拟在体动脉内膜的三维培养模型。我们提供的证据表明,nLDL和氧化LDL可能作为一个潜在的介质,增加释放的ET-1在高脂血症和动脉粥样硬化。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Haraoka S, Shimokawa T, Watanabe T: "Role of T lymphocytes in the pathogenesis of atherosclerosis,Animal studies using athymic nude rats" Annals of New York Academy of Sciences. 811. 515-518 (1997)
Haraoka S、Shimokawa T、Watanabe T:“T 淋巴细胞在动脉粥样硬化发病机制中的作用,使用无胸腺裸鼠的动物研究”纽约科学院年鉴。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Bobryshev Y.V, Ikezawa T, Watanabe T.: "Formation of Birbeck granule-like structures in vascular dendritic cells in human atherosclerotic aorta" Atherosclerosis. 133. 193-202 (1997)
Bobryshev Y.V、Ikezawa T、Watanabe T.:“人动脉粥样硬化主动脉血管树突状细胞中伯贝克颗粒样结构的形成”动脉粥样硬化。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Watanabe,T et al.: "Inflammatory and immune nature of atherosclerosis." Int.J.Cardiol.54. s25-s34 (1996)
Watanabe,T 等人:“动脉粥样硬化的炎症和免疫性质。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Haraoka, S. et al.: "Participation of T lymphocytes in atherogenesis: sequential and quantitative observation of aortic ・・・" Virchows Arch.426. 307-315 (1995)
Haraoka, S. 等人:“T 淋巴细胞参与动脉粥样硬化形成:主动脉的连续和定量观察......” Virchows Arch.426 (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsumoto,S et al.: "Molecular cloning of rabbit matrix metalloproteinase-2 and its broad expression at several tissues." Bioch.Biophys.Acta. 1307. 137-139 (1996)
Matsumoto,S 等人:“兔基质金属蛋白酶-2 的分子克隆及其在多种组织中的广泛表达。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WATANABE Teruo其他文献
WATANABE Teruo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WATANABE Teruo', 18)}}的其他基金
Effects of MMP-9 on plaque rupture: development of a novel model for acute coronary syndromes.
MMP-9 对斑块破裂的影响:急性冠脉综合征新型模型的开发。
- 批准号:
23590401 - 财政年份:2011
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of disease-specific MMP to conquer acute coronary syndrome ?study with transgenic rabbit
疾病特异性MMP征服急性冠脉综合征的研究——转基因兔研究
- 批准号:
20590343 - 财政年份:2008
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of MMP-12 functions in atherosclerosis using transgenic rabbit models
使用转基因兔模型阐明 MMP-12 在动脉粥样硬化中的功能
- 批准号:
13470046 - 财政年份:2001
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DEVELOPMENT OF CLONE TRANSGENIC RABBITS FOR THE STUDY OF ATHEROSCLEROSIS
用于动脉粥样硬化研究的克隆转基因兔的开发
- 批准号:
11557016 - 财政年份:1999
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of apo (a) in atherogenesis. A study using transgenic rabbits expressing human apo (a)
apo (a) 在动脉粥样硬化形成中的作用。
- 批准号:
10470046 - 财政年份:1998
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Reconstruction of Early Paleozoic arc-trench system: a case study in the eastern Gondwana margin
早古生代弧沟系统的重建——以冈瓦纳大陆边缘东部为例
- 批准号:
10041102 - 财政年份:1998
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Development of transgenic rabbits as models for atherosclerotic research
开发转基因兔作为动脉粥样硬化研究模型
- 批准号:
08557017 - 财政年份:1996
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of a 3- dimensional culture model system simulating arterial intima and its application for atherosclerosis study.
模拟动脉内膜的三维培养模型系统的开发及其在动脉粥样硬化研究中的应用。
- 批准号:
05557016 - 财政年份:1993
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Reconstruction of pre-breakup Paleozoic-suture of Gondowana continent in Australia
澳大利亚冈多瓦纳大陆裂解前古生代缝合带的重建
- 批准号:
04041012 - 财政年份:1992
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for international Scientific Research
Role of Macrophages and Immune Cells in Atherogenesis
巨噬细胞和免疫细胞在动脉粥样硬化形成中的作用
- 批准号:
04454181 - 财政年份:1992
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Understanding how the interaction between Lag3 deficiency and hypercholesterolemia impact anti-tumor immunity and cardiovascular disease in a melanoma model
了解 Lag3 缺乏与高胆固醇血症之间的相互作用如何影响黑色素瘤模型中的抗肿瘤免疫和心血管疾病
- 批准号:
10637369 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Nonviral delivery of CRISPR-Cas9 into hepatocytes combined with APAP selection for treatment of Familial Hypercholesterolemia
将 CRISPR-Cas9 非病毒递送至肝细胞结合 APAP 选择治疗家族性高胆固醇血症
- 批准号:
10905153 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Comparing Direct and Indirect Methods for Cascade Screening in Familial Hypercholesterolemia (FH) and Long QT Syndrome (LQTS)
比较家族性高胆固醇血症 (FH) 和长 QT 综合征 (LQTS) 的直接和间接级联筛查方法
- 批准号:
10640932 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Knowledge to Action: Developing a Knowledge Translation Strategy to Improve Screening, Diagnosis, and Treatment of Familial Hypercholesterolemia in British Columbia Based on the New 2022 Canadian Pediatric Lipid Guidelines
将知识转化为行动:根据新的 2022 年加拿大儿科血脂指南制定知识转化策略,以改善不列颠哥伦比亚省家族性高胆固醇血症的筛查、诊断和治疗
- 批准号:
486221 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Studentship Programs
Study on the feline lipid metabolism for prevention of hypercholesterolemia in mammals
猫脂质代谢预防哺乳动物高胆固醇血症的研究
- 批准号:
22K19321 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
IMPLEMENTING MULTICOMPONENT INTERVENTIONS TO TREAT BLOOD DONORS WITH FAMILIAL HYPERCHOLESTEROLEMIA
实施多成分干预措施治疗患有家族性高胆固醇血症的献血者
- 批准号:
10368003 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)
改善家族性高胆固醇血症的风险分层 (RISK-FH)
- 批准号:
10651732 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH
帮助每个患有家族性高胆固醇血症的人的协作方法:CARE-FH
- 批准号:
10368422 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
与 FH 基金会合作,利用行为经济学对家族性高胆固醇血症患者公平地实施级联筛查
- 批准号:
10585100 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
与 FH 基金会合作,利用行为经济学对家族性高胆固醇血症患者公平地实施级联筛查
- 批准号:
10367999 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别: